Indian Journal of Drugs in Dermatology

CASE REPORT
Year
: 2019  |  Volume : 5  |  Issue : 1  |  Page : 42--45

“PRIDE” Complex: A Report of Two Cases


Shashank Krishna Agrawal, Bhagyashree Babanrao Supekar, Vaishali Wankhade, Rajesh Pratap Singh 
 Department of Dermatology, Venereology and Leprosy, Government Medical College, Nagpur, Maharashtra, India

Correspondence Address:
Dr. Bhagyashree Babanrao Supekar
Department of Dermatology, Venereology and Leprosy, Government Medical College, Nagpur, Maharashtra
India

Epidermal growth factor receptor inhibitors are currently widely used for the treatment of nonsmall cell lung cancer and head-and-neck malignancy. These are associated with constellation of cutaneous reactions termed as PRIDE complex which comprises papulopustules and/or paronychia, regulatory abnormalities of hair growth, itching, and dryness. We report two cases of PRIDE complex, diagnosed clinically and histopathologically in patients of nonsmall cell carcinoma of the lung being treated with erlotinib and gefitinib.


How to cite this article:
Agrawal SK, Supekar BB, Wankhade V, Singh RP. “PRIDE” Complex: A Report of Two Cases.Indian J Drugs Dermatol 2019;5:42-45


How to cite this URL:
Agrawal SK, Supekar BB, Wankhade V, Singh RP. “PRIDE” Complex: A Report of Two Cases. Indian J Drugs Dermatol [serial online] 2019 [cited 2020 Oct 30 ];5:42-45
Available from: https://www.ijdd.in/article.asp?issn=2455-3972;year=2019;volume=5;issue=1;spage=42;epage=45;aulast=Agrawal;type=0